Adaptive biotechnologies president & COO Rubinstein sells $897k stock
Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp, sold $897,355 worth of shares last week. The sales, made under a trading plan, saw her dispose of 35,643 shares at prices between $24.21 and $25.82. This occurred on October 14, 15, and 16, 2026. Despite the recent 71% increase in the stock price, Rubinstein's sale resulted in no change to her overall ownership in the company.
Simultaneously, she bought shares using exercised stock options, acquiring 11,881 more shares at $12.14 per share, valued at approximately $432,706. Adaptive Biotechnologies reported a loss of $0.25 per share in its second quarter, though revenue of $71.6 million exceeded analysts' expectations by 22%. Investment firms have varied opinions on Adaptive Biotechnologies, with some raising their price targets and others maintaining buy ratings.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
